How New HPV Vaccine Reduces Risk Of HPV-Related Diseases

Cervical cancer causes approximately 300,000 deaths annually and is the second most common cause of cancer-related death. Nearly, more than 80 percent of deaths resulting from cervical cancer occur in the developing nations. The onset of human papillomavirus (HPV) vaccines was found to notably reduce the number of cervical cancer and their related deaths. The research team along with those from Moffitt Cancer Center published their final results in The Lancet showing that the newest 9vHPV vaccine is highly effective in preventing HPV infection and disease.